{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:32:20Z","timestamp":1768534340581,"version":"3.49.0"},"reference-count":76,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1590\/0074-02760140346","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T14:01:53Z","timestamp":1421330513000},"page":"114-124","source":"Crossref","is-referenced-by-count":1,"title":["Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation - technological development issues"],"prefix":"10.1590","volume":"110","author":[{"given":"Reinaldo de Menezes","family":"Martins","sequence":"first","affiliation":[{"name":"Bio-Manguinhos-Fiocruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina de Albuquerque","family":"Possas","sequence":"additional","affiliation":[{"name":"Bio-Manguinhos-Fiocruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Homma","sequence":"additional","affiliation":[{"name":"Bio-Manguinhos-Fiocruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Vaccines, a biography, Springer","author":"Artenstein AW","year":"2010"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0264-410X(02)00721-1","article-title":"BCG (Bacille of Calmette-Gu\u00e9rin) revaccination leads to improved in vitro IFN-\u03b3 response to mycobacterial antigen independent of tuberculin sensitization in Brazilian school-age children","author":"Barbosa T","year":"2003","journal-title":"Vaccine 21"},{"key":"ref3","series-title":"Febre amarela - a doen\u00e7a e a vacina, uma hist\u00f3ria inacabada","author":"Benchimol JL","year":"2001"},{"key":"ref4","first-page":"351","article-title":"Enhancing antibody immunogenicity of transmission-blocking malaria vaccines","volume":"89","author":"Biswas S","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref5","first-page":"15","article-title":"The value of vaccination","volume":"6","author":"Bloom DE","year":"2005","journal-title":"World Economics"},{"key":"ref6","first-page":"299","article-title":"Prevalence of antibodies against measles, mumps and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil","volume":"20","author":"Boaventura AS","year":"2006","journal-title":"Rev Panam Salud Publica"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1590\/S0034-89102005000300012","article-title":"Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial","volume":"39","author":"Camacho LAB","year":"2005","journal-title":"Rev Saude Publica"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0034-89102004000500009","article-title":"Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial","volume":"38","author":"Camacho LAB","year":"2004","journal-title":"Rev Saude Publica"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/S0034-89102000000400008","article-title":"Estudo de soroconvers\u00e3o com formula\u00e7\u00f5es da vacina BIKEN CAM-70 contra sarampo","volume":"34","author":"Camacho LAB","year":"2000","journal-title":"Rev Saude Publica"},{"key":"ref10","first-page":"100","article-title":"Risco de infec\u00e7\u00e3o tuberculosa entre escolares com alta cobertura pelo BCG","volume":"108","author":"Camacho LAB","year":"1990","journal-title":"Bol Oficina Sanit Panam"},{"key":"ref11","first-page":"1","article-title":"17DD and 17D-213\/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children","volume":"7","author":"Campi-Azevedo AC","year":"2012","journal-title":"PLoS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S0037-86822003000300002","article-title":"Feasibility study of the immunogenicity and safety of a novel DTPw\/Hib (PRP-T) Brazilian combination compared to a licensed vaccine in healthy children at 2, 4 and 6 months of age","volume":"36","author":"Clemens SA","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","article-title":"Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis","volume":"17","author":"De Luca PM","year":"1999","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0001-706X(01)00181-4","article-title":"A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis","volume":"80","author":"De Luca PM","year":"2001","journal-title":"Acta Trop"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","article-title":"Generalized urticaria induced by theNa-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths","volume":"150","author":"Diemert DJ","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0074-02762005000300021","article-title":"Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus","volume":"100","author":"dos Santos AP","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0074-02762007000100020","article-title":"The sample processing time interval as an influential fator in flow cytometry analysis of lymphocyte subsets","volume":"102","author":"dos Santos AP","year":"2007","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref18","first-page":"93","article-title":"The duration of immunity following vaccination with the 17D strain of yellow fever virus","volume":"37","author":"Fox JP","year":"1943","journal-title":"Am J Hyg"},{"key":"ref19","first-page":"64","article-title":"Additional observations on the duration of immunity following vaccination with the 17D strain of yellow fever virus","volume":"47","author":"Fox JP","year":"1948","journal-title":"Am J Hyg"},{"key":"ref20","first-page":"113","article-title":"Field studies on the immune response to 17D yellow fever virus","volume":"38","author":"Fox JP","year":"1943","journal-title":"Am J Hyg"},{"key":"ref21","first-page":"117","article-title":"Encephalitis in man following vaccination with 17D yellow fever virus","volume":"36","author":"Fox JP","year":"1942","journal-title":"Am J Hyg"},{"key":"ref22","first-page":"68","article-title":"Observations on the occurrence of icterus in Brazil following vaccination against yellow fever","volume":"36","author":"Fox JP","year":"1942","journal-title":"Am J Hyg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.17525\/vrrjournal.v7i1.202","article-title":"Seroconversion following vaccination with the 17DD substrain of yellow fever virus","volume":"7","author":"Freire MS","year":"2002","journal-title":"Virus Rev Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"354","author":"Giuliano AR","year":"2011","journal-title":"N Engl J Med"},{"key":"ref25","first-page":"699","article-title":"Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine","volume":"27","author":"Groot H","year":"1962","journal-title":"Bull World Health Organ"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/CVI.05208-11","article-title":"Immunogenicity of the quadrivalent human papillomavirus (type 6\/11\/16\/18) vaccine in males 16 to 26 years old","volume":"19","author":"Hillman RJ","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref27","series-title":"The structure of scientific revolutions","author":"Kuhn TS","year":"1970","edition":"2nd ed."},{"key":"ref28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1590\/S0021-75572001000600013","article-title":"Pesquisa de anticorpos contra o sarampo em crian\u00e7as infectadas pelo HIV ap\u00f3s imuniza\u00e7\u00e3o b\u00e1sica","volume":"77","author":"Lindgren-Alves CR","year":"2001","journal-title":"J Pediatr (Rio J)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0092-1157(88)90034-0","article-title":"Studies on yellow fever vaccine. III - Dose response in volunteers","volume":"16","author":"Lopes OS","year":"1988","journal-title":"J Biol Stand"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/infdis\/jir439","article-title":"Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody","volume":"204","author":"Luiza-Silva M","year":"2011","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.vaccine.2010.08.046","article-title":"Characterization of main cytokine sources from the innate and adaptive imune responses following primary 17DD yellow fever vaccination in adults","volume":"29","author":"Luiza-Silva M","year":"2011","journal-title":"Vaccine"},{"key":"ref32","first-page":"1","article-title":"Efficacy and safety of the Brazilian vaccine against hepatitis B in newborns","volume":"43","author":"Luna EJ","year":"2009","journal-title":"Rev Saude Publica"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-4362.2002.01336.x","article-title":"Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killedLeishmania amazo- nensisvaccine plus antimonial","volume":"41","author":"Machado-Pinto J","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins MA","year":"2008","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2249.2006.03317.x","article-title":"Activation\/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?","volume":"148","author":"Martins MA","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref36","series-title":"An\u00e1lises de estudos cl\u00ednicos com vacinas realizados no \u00e2mbito do Instituto Oswaldo Cruz e Fiocruz - mem\u00f3ria, avalia\u00e7\u00e3o e li\u00e7\u00f5es","author":"Martins RM","year":"2014"},{"key":"ref37","first-page":"p. 169","author":"Martins RM","year":"2010"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1590\/S0074-02762004000800014","article-title":"Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B","volume":"99","author":"Martins RM","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1590\/S0074-02762008000700014","article-title":"Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis andHaemophilus influenzaeType b","volume":"103","author":"Martins RM","year":"2008","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref40","series-title":"Phase I safety and immunogenicity study of a serogroup C conjugate vaccine - Lessons learned","first-page":"p. 41","author":"Martins RM","year":"2009"},{"key":"ref41","series-title":"Din\u00e2mica das doen\u00e7as infecciosas e parasit\u00e1rias","first-page":"p. 431","volume-title":"Imuniza\u00e7\u00f5es","author":"Martins RM","year":"2013"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.22982","article-title":"17DD yellow fever vaccine. A Double blind, randomized clinical trial of immunogenicity and safety on a dose-response study","volume":"9","author":"Martins RM","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref43","first-page":"p. 40","article-title":"Phase I safety and immunogenicity study of a Brazilian bivalent serogroup B vaccine","author":"Martins RM","year":"2009","journal-title":"Neisseria vaccines 2009"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0074-02761998000200014","article-title":"Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil","volume":"93","author":"Marzochi KBF","year":"1998","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/tropej\/48.2.93","article-title":"Rotavirus G serotypes and P[], G genotypes identified in cases of reinfection among children participating in a trial with rhesus-human reassortant tetravalent vaccine (RRV-TV) in Bel\u00e9m, Brazil","volume":"48","author":"Mascarenhas JDP","year":"2002","journal-title":"J Trop Pediatr"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762002000100020","article-title":"Detection and characterization of rotavirus G and P types from children participating in a rotavirus vaccine trial in Bel\u00e9m, Brazil","volume":"97","author":"Mascarenhas JDP","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1590\/S0100-879X2009005000039","article-title":"Pattern of functional antibody activity againstHaemophilus influenzaeType b (Hib) in infants immunized with diphtheria-tetanus-pertussis\/Hib Brazilian combination vaccine","volume":"42","author":"Matos DCS","year":"2009","journal-title":"Braz J Med Biol Res"},{"key":"ref48","first-page":"1","article-title":"T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and II binding motifs","volume":"7","author":"Melo AB","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4269\/ajtmh.2011.10-0496","article-title":"Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil","volume":"85","author":"Melo AB","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4269\/ajtmh.1995.53.195","article-title":"Characterization of human T lymphocyte-mediated immune responses induced by a vaccine against American tegumentary leishmaniasis","volume":"53","author":"Mendon\u00e7a SCF","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref51","first-page":"1","article-title":"Immunogenicity of the Brazilian hepatitis B vaccine in adults","volume":"44","author":"Moraes JC","year":"2010","journal-title":"Rev Saude Publica"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4161\/hv.7.7.15579","article-title":"Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescentes and young adults","volume":"7","author":"Moreira Jr ED","year":"2011","journal-title":"Hum Vaccin"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0264-410X(01)00493-5","article-title":"Immunogenicity of hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life","volume":"20","author":"Motta MSF","year":"2002","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1590\/S0102-311X2009000400004","article-title":"Compliance with and response to hepatitis B vaccination in remaining quilombo communities in central Brazil","volume":"25","author":"Motta-Castro ARC","year":"2009","journal-title":"Cad Saude Publica"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1016\/j.vaccine.2010.07.063","article-title":"A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis","volume":"28","author":"Nascimento E","year":"2010","journal-title":"Vaccine"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.vaccine.2009.07.028","article-title":"TLR expression and NK activation after human yellow fever vaccination","volume":"27","author":"Neves PCC","year":"2009","journal-title":"Vaccine"},{"key":"ref57","first-page":"121","article-title":"Vacina CAM-70 contra o sarampo produzida no Brasil. Avalia\u00e7\u00f5es de campo em crian\u00e7as com 6-12 meses de idade","volume":"18","author":"Oliva OP","year":"1986","journal-title":"Boletim Epidemiol\u00f3gico"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/j.vaccine.2013.04.079","article-title":"Interferon-gamma production by mononuclear cells in Bacille Calmette-Gu\u00e9rin-revaccinated healthy volunteers predicted long-term antimycobacterial responses in a randomized controlled trial","volume":"31","author":"Oliveira ES","year":"2013","journal-title":"Vaccine"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky JM","year":"2011","journal-title":"N Engl J Med"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(88)91229-9","article-title":"Randomised trial of alternative formulations of oral poliovaccine in Brazil","volume":"27","author":"Patriarca PA","year":"1988","journal-title":"Lancet"},{"key":"ref61","series-title":"History of vaccine development","author":"Plotkin AS","year":"2011"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1016\/j.vaccine.2012.07.028","article-title":"Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults","volume":"30","author":"Potsch DV","year":"2012","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.vaccine.2009.11.066","article-title":"High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected subjects","volume":"28","author":"Potsch DV","year":"2010","journal-title":"Vaccine"},{"key":"ref64","series-title":"Caracter\u00edsticas de la mortalidad en la ni\u00f1ez: informe de la Investigaci\u00f3n Interamericana de la Ni\u00f1ez","author":"Puffer RR","year":"1973"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0039310","article-title":"H1N1 pdm09 adjuvanted vaccination in HIV-infected adults: a randomized trial of two singleversustwo double doses","volume":"7","author":"Santini-Oliveira M","year":"2012","journal-title":"PLoS ONE"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2008.02.007","article-title":"Detection of TH1\/ TH2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay","volume":"42","author":"Santos AP","year":"2008","journal-title":"Cytokine"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.nano.2013.04.003","article-title":"PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania","volume":"9","author":"Santos DM","year":"2013","journal-title":"Nanomedicine"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1590\/S0037-86821969000600003","article-title":"Avalia\u00e7\u00e3o sorol\u00f3gica da vacina oral, tipo Sabin, contra a poliomielite, em regi\u00e3o semi-rural. I. Forma\u00e7\u00e3o de anticorpos em vacinados","volume":"3","author":"Schatzmayr HG","year":"1969","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0264-410X(86)90048-4","article-title":"Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil","volume":"4","author":"Schatzmayr HG","year":"1986","journal-title":"Vaccine"},{"key":"ref70","first-page":"242","article-title":"Serological response to measles vaccine (Schwarz strain) in a low-income population at Rio de Janeiro","volume":"13","author":"Schatzmayr HG","year":"1982","journal-title":"Rev Microbiol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1016\/j.vaccine.2011.05.019","article-title":"Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella","volume":"29","author":"Silva JRN","year":"2011","journal-title":"Vaccine"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4269\/ajtmh.1938.s1-18.437","article-title":"Yellow fever vaccination with cultured virus (17D) without immune serum","volume":"18","author":"Smith HH","year":"1938","journal-title":"Am J Trop Med Hyg"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4269\/ajtmh.1938.s1-18.111","article-title":"Yellow fever vaccination with cultivated virus and immune and hyperimmune serum","volume":"18","author":"Soper FL","year":"1938","journal-title":"Am J Trop Med Hyg"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0264-410X(98)00320-X","article-title":"Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine","volume":"17","author":"Stefano I","year":"1999","journal-title":"Vaccine"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1590\/S0037-86821996000500014","article-title":"Safety evaluation of SPf66 malaria vaccine in Brazil","volume":"29","author":"Urdaneta M","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.1998.58.378","article-title":"Evaluation of SPf66 malaria vaccine efficacy in Brazil","volume":"58","author":"Urdaneta M","year":"1998","journal-title":"Am J Trop Med Hyg"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/mioc\/v110n1\/0074-0276-mioc-0074-02760140346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T03:23:40Z","timestamp":1495509820000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762015000100114&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0074-02762015000100114"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760140346","relation":{},"ISSN":["0074-0276"],"issn-type":[{"value":"0074-0276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}